Towa Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sale ethical drugs in Japan. It operates through two segments; Domestic and Overseas. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products, as well as provide formulations from Tablets, Capsules, Injectable, Patches, eye drops, and other products. It also offers IT service related to healthcare; disease risk testing services; and quasi drugs. In addition, the company is involved in research and development and production of active pharmaceutical ingredients, intermediates, support business; and planning, development and OEM manufacturing of health foods, pharmaceuticals, general foods, and other miscellaneous merchandizes. The company was founded in 1951 and is headquartered in Osaka, Japan.
Metrics to compare | 4553 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4553PeersSector | |
---|---|---|---|---|
P/E Ratio | 9.1x | 13.7x | −0.5x | |
PEG Ratio | −1.67 | 0.22 | 0.00 | |
Price/Book | 0.8x | 1.0x | 2.6x | |
Price / LTM Sales | 0.6x | 1.5x | 3.3x | |
Upside (Analyst Target) | 42.5% | 11.6% | 42.9% | |
Fair Value Upside | Unlock | 14.2% | 6.2% | Unlock |